Brought to you by 
Meristem Therapeutics, Goodwin Biotechnology in alliance
22 Jun 2022
Executive Summary
Goodwin Biotechnology (recombinant products manufacturer) will help Meristem Therapeutics (phytopharmaceuticals) set up a facility in Florida for its Molecular Pharming technology, which will extract and purify recombinant proteins from plants. The two companies will then offer customers Meristem Therapeutics' Molecular Pharming to generate clinical trial materials in conjunction with Goodwin Biotechnology's cell culture technologies.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D (No Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Meristem Therapeutics, Goodwin Biotechnology in alliance
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice